Human Metabolome Technologies, Inc.
Human Metabolome Technologies (HMT) is a CRO metabolomics company partnering with clients using our patented capillary electrophoresis (CE-MS) and LCMS platforms. We are a global company with offices in USA, EU and Japan.
HMT enables our clients to discovery critical pathways for biomarker discovery, enhance drug development, perform plasma, tissue and urine screening to uncover mechanisms of action through the profiling of over 2,000 polar metabolites using high resolution, high performance CE-MS and providing LC-MS solutions for hundreds of lipid metabolites characteristic of kidney disease.